Panel 3: A Value-Based Approach to Drug Pricing (Unpacking Drug Value) | Kaiser Permanente

Panel 1: Defining & Assessing Drug Value (Unpacking Drug Value) | Kaiser PermanenteПодробнее

16 Value Based Drug Payment and Utilization Gabriela LavezzariПодробнее

Morning Keynote (Unpacking Drug Value): | Kaiser PermanenteПодробнее

Solutions Panel (Addressing High Drug Pricing Forum) | Kaiser PermanenteПодробнее

Panel 2: Paying for Value (Unpacking Drug Value) | Kaiser PermanenteПодробнее

Themes Emerging from the Unpacking Drug Value Forum | Kaiser PermanenteПодробнее

Unpacking Drug Value | Kaiser PermanenteПодробнее

Views from Industry (Unpacking Drug Value) | Kaiser PermanenteПодробнее

The Nature of the Problem Panel (Addressing High Drug Pricing Forum) | Kaiser PermanenteПодробнее

Scaling Value: New challenges and approaches to drug pricingПодробнее

Speaker Series: A Multifaceted Approach to Combatting Rising Drug Costs | Kaiser PermanenteПодробнее

Drug Pricing Policy Summit 2017: Panel 1 - Value Based Health Outcomes MeasurementПодробнее

Value-Based Cancer Care: The Threat of Soaring Drug CostsПодробнее

Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug PricingПодробнее

2016 Rx Forum: "Value Based Pricing"Подробнее

How does Kaiser Permanente define value?Подробнее

6/9, Session 3: Value-Based Drug PricingПодробнее

Welcome & Opening Remarks (Unpacking Drug Value) | Kaiser PermanenteПодробнее

Addressing High Drug Pricing | Kaiser PermanenteПодробнее